Literature DB >> 35286587

The importance of diaphragmatic surgery, chemical pleurodesis and postoperative hormonal therapy in preventing recurrence in catamenial pneumothorax: a retrospective cohort study.

Alessio Campisi1,2, Angelo Paolo Ciarrocchi3, Giorgio Grani3, Stefano Sanna3, Stefano Congiu3, Sara Mazzarra3, Desideria Argnani3, Maurizio Salvi3, Franco Stella3.   

Abstract

BACKGROUND: Catamenial pneumothorax (CP) is defined as a recurrent, spontaneous pneumothorax occurring within a day before or 72 h after the onset of menstruation. Most first episodes go undiagnosed and treated as primary spontaneous pneumothorax, and only after recurrence is the clinical suspicion of CP raised. No gold-standard management approach exists, especially in terms of managing diaphragmatic involvement.
METHODS: This study is a single-centre cohort retrospective study of 24 female patients who underwent surgery for pneumothorax due to diaphragmatic endometriosis between January 2008 and December 2016. Two groups were compared: a group that underwent pleurodesis alone (8 patients) and a group that underwent diaphragmatic surgery and pleurodesis (16 patients).
RESULTS: There were differences in BMI and smoking habits between the two groups. The right diaphragm was involved more often (6vs15, p = 0.190). VATS was the preferred surgical approach and only one conversion occurred in the diaphragmatic surgery group (p = 0.470). Diaphragmatic abnormalities were present in all the patients, brown/violet spots (100%) in the pleurodesis group and perforations (100%) in the diaphragmatic surgery group (p < 0.001). There were no differences in days of chest tube removal and length of stay. The recurrence rate was 100% in the pleurodesis alone group while it was only 12.5% in the diaphragmatic surgery group (< 0.001).
CONCLUSIONS: In our experience, diaphragmatic surgery and pleurodesis followed by hormonal therapy was an effective approach in preventing recurrence in patients with catamenial pneumothorax and diaphragmatic involvement.
© 2022. The Author(s), under exclusive licence to The Japanese Association for Thoracic Surgery.

Entities:  

Keywords:  Catamenial pneumothorax; Diaphragmatic surgery; Endometriosis; Hormone therapy; Video-assisted thoracoscopic surgery (VATS)

Mesh:

Year:  2022        PMID: 35286587     DOI: 10.1007/s11748-022-01802-w

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  2 in total

1.  Current therapy of catamenial pneumothorax.

Authors:  H F Tripp; L P Thomas; J A Obney
Journal:  Heart Surg Forum       Date:  1998       Impact factor: 0.676

2.  Catamenial pneumothorax.

Authors:  C H Soderberg; E H Dahlquist
Journal:  Surgery       Date:  1976-02       Impact factor: 3.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.